|
2025
|
Invention
|
Methods of reducing or hindering development of ischemia-reperfusion injury due to kidney transpl... |
|
2024
|
P/S
|
Chemical and biological reagents for industrial use for anti-body screening, blood grouping, and ... |
|
|
Invention
|
Method of treatment of philadelphia chromosome positive leukemia.
The invention provides a metho... |
|
|
Invention
|
Antibodies against g-csfr and uses thereof.
The present disclosure provides proteins comprising ... |
|
|
Invention
|
Reconstituted hdl formulation.
The present invention relates to reconstituted high density lipop... |
|
|
P/S
|
Influenza vaccines for human use. |
|
|
P/S
|
Influenza vaccines for human use. |
|
|
P/S
|
Influenza vaccines for human use |
|
2023
|
Invention
|
Anti-tumor compositions and uses thereof.
The present invention provides a composition for raisi... |
|
|
Invention
|
Cd131 binding proteins and uses thereof.
The present disclosure provides a CD131-binding protein... |
|
|
Invention
|
Dosage regime for apolipoprotein formulations.
An apolipoprotein formulation is provided at a fi... |
|
|
Invention
|
Reconstituted high density lipoprotein treatment of myocardial infarction.
Reconstituted HDL for... |
|
|
P/S
|
Pharmaceutical preparations and substances for immunoglobulin therapy, the treatment and preventi... |
|
2022
|
Invention
|
Method of treating or preventing liver conditions.
The present disclosure provides a method of t... |
|
|
P/S
|
Providing medical and scientific research information in the field of pharmaceuticals and clinica... |
|
|
P/S
|
Promoting public awareness of blood diseases, illnesses and conditions; promoting awareness of va... |
|
|
Invention
|
Reconstituted hdl formulation. The present invention relates to reconstituted high density lipopr... |
|
|
Invention
|
Human serum albumin variants and uses thereof.
A serum albumin variant, or functional fragment t... |
|
2021
|
Invention
|
Coagulation factor binding proteins and uses thereof.
A membrane targeted binding protein that b... |
|
|
Invention
|
Reconstituted high density lipoprotein formulation and production method thereof. A reconstituted... |
|
|
P/S
|
Vaccines. |
|
2020
|
Invention
|
Method for improving the stability of purified factor viii after reconstitution. The present disc... |
|
|
Invention
|
Cd131 binding proteins and uses thereof. The present disclosure provides a CD131-binding protein ... |
|
|
Invention
|
Method of treating cancer.
The present disclosure provides a method for enhancing or inducing an... |
|
|
Invention
|
Contaminant removal method. A method for purifying Apo A-I is provided including the steps of pro... |
|
|
Invention
|
Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (g... |
|
|
P/S
|
Promoting awareness of blood diseases, illnesses and conditions; promoting awareness of vaccines ... |
|
|
Invention
|
Treatment employing anti-il-13r antibody or binding fragment thereof. The present disclosure prov... |
|
2019
|
Invention
|
Method of treating neutrophilic conditions.
The present disclosure relates to a method for reduc... |
|
|
Invention
|
Methods of administering inhibitory anti-factor xii/xiia monoclonal antibodies. The invention rel... |
|
|
Invention
|
Method for polishing albumin.
The present invention provides a method of polishing albumin to re... |
|
|
Invention
|
Method of treating wasting disorders.
The present disclosure provides a method of treating a was... |
|
|
Invention
|
Process for preparing apolipoprotein a-i (apo a-i). The present invention relates to processes of... |
|
|
Invention
|
Method of treating wasting disorders. The present disclosure provides a method of treating a wast... |
|
|
Invention
|
Methods of treating diabetic nephropathy by administering an anti-vegf-b (vascular endothelial gr... |
|
|
Invention
|
Method of inhibition of leukemic stem cells.
A method for inhibition of leukemic stem cells expr... |
|
|
Invention
|
Soluble complement receptor type 1 variants and uses thereof. A method of inhibiting complement a... |
|
|
Invention
|
Method of reducing the effect of a stroke comprising administering an inhibitor of vascular endot... |
|
|
Invention
|
Method of treating asthma. The present disclosure relates to methods of treating asthma, such as ... |
|
2018
|
Invention
|
Agents that neutralize il-3 signalling and uses thereof.
The present disclosure relates to compo... |
|
|
Invention
|
Use of a fxiia-inhibitor in the treatment of renal fibrosis and/or chronic kidney disease. The in... |
|
|
Invention
|
Method of treating or preventing ischemia-reperfusion injury.
The present disclosure relates to ... |
|
|
Invention
|
Method of treating or preventing ischemia-reperfusion injury. The present disclosure relates to a... |
|
|
Invention
|
Method.
The invention relates to an antibody to a red blood cell for use in treating or preventi... |
|
|
Invention
|
Human serum albumin variants and uses thereof. A serum albumin variant, or functional fragment th... |
|
|
Invention
|
Financial method.
The present invention provides a composition for raising an immune response ag... |
|
|
Invention
|
Method of treatment using il-13r antibody.
The present disclosure provides a method of treating ... |
|
|
P/S
|
Influenza vaccines for human use |
|
|
P/S
|
[ Processing of human blood plasma, namely, removing whole blood and separating red blood cells f... |
|
2017
|
P/S
|
[ Treatment of biological products, namely, custom manufacturing and fractionation of blood ] [ P... |
|
|
Invention
|
Method of treating atherosclerosis. The present disclosure relates to a method of treating or pre... |
|
|
P/S
|
Vaccines for human use, namely influenza vaccines |
|
|
P/S
|
Antibodies for use in the treatment of [ infectious diseases, cancer and ] autoimmune diseases; [... |
|
|
P/S
|
Pharmaceutical preparations and substances for the prevention or treatment of influenza; influenz... |
|
|
P/S
|
Pharmaceutical preparations and substances for the
prevention or treatment of influenza; influen... |
|
2016
|
P/S
|
[ Chemical and biological reagents for non-medical purposes; chemical and biological reagents for... |
|
|
P/S
|
Pharmaceutical preparations and substances; pharmaceuticals
for the treatment or prevention of b... |
|
2015
|
P/S
|
Blood bank services; medical services; medical testing and screening services for diagnostic or t... |
|
2014
|
P/S
|
Chemical and biological reagents for clinical and medical use and for non-medical purposes namely... |
|
|
P/S
|
Chemical and biological reagents included in this class;
cell cultures and media included in thi... |
|
2012
|
P/S
|
Pharmaceutical preparations and substances in this class;
vaccines; blood products in this class... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment and prevention of blood and bleeding... |
|
|
P/S
|
Pharmaceutical preparations and substances; blood products
and products derived from blood; bloo... |
|
2011
|
P/S
|
Pharmaceutical preparations and substances; pharmaceutical
preparations for the treatment of blo... |
|
2010
|
P/S
|
Normal immunoglobulin; pharmaceutical preparations and
substances; blood products for the treatm... |
|
2009
|
P/S
|
Influenza vaccine for human use. |
|
|
P/S
|
Transport and storage of goods namely transport, distribution and storage of blood plasma, transp... |
